 | Fate Therapeutics, Inc. | |||
| NGM : FATE || Location: United States | ||||
$3.87-0.43 (-10.0%) |
3.6 M | 3.78 - 4.15 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 18.921 M |
| March 28, 2024 | 16.485 M |
| March 15, 2024 | 13.158 M |
| Feb. 29, 2024 | 13.491 M |
| Feb. 15, 2024 | 13.312 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.53 | -0.45 | 15.59% |
| 09/30/2023 | -0.58 | -0.46 | 20.87% |
| 06/30/2023 | -0.60 | -0.54 | 10.02% |
| 03/31/2023 | -0.64 | -0.19 | 70.10% |
| 12/31/2022 | -0.88 | -0.58 | 33.99% |
FATE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 113.783M | Shares Float | 80.652M |
| Short Float | 18.921M | Market Cap | 489.27M |
| Institution ownership | 91.82% | Insider ownership | 1.470% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.64 | Forward EPS | -1.81 |